Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Nov 29;16(11):e0260364. doi: 10.1371/journal.pone.0260364

The effectiveness of Non-pharmaceutical interventions in reducing the COVID-19 contagion in the UK, an observational and modelling study

Giorgos Galanis 1,#, Corrado Di Guilmi 2,, David L Bennett 3,, Georgios Baskozos 3,*,#
Editor: Prasenjit Mitra4
PMCID: PMC8629270  PMID: 34843552

Abstract

Epidemiological models used to inform government policies aimed to reduce the contagion of COVID-19, assume that the reproduction number is reduced through Non-Pharmaceutical Interventions (NPIs) leading to physical distancing. Available data in the UK show an increase in physical distancing before the NPIs were implemented and a fall soon after implementation. We aimed to estimate the effect of people’s behaviour on the epidemic curve and the effect of NPIs taking into account this behavioural component. We have estimated the effects of confirmed daily cases on physical distancing and we used this insight to design a behavioural SEIR model (BeSEIR), simulated different scenaria regarding NPIs and compared the results to the standard SEIR. Taking into account behavioural insights improves the description of the contagion dynamics of the epidemic significantly. The BeSEIR predictions regarding the number of infections without NPIs were several orders of magnitude less than the SEIR. However, the BeSEIR prediction showed that early measures would still have an important influence in the reduction of infections. The BeSEIR model shows that even with no intervention the percentage of the cumulative infections within a year will not be enough for the epidemic to resolve due to a herd immunity effect. On the other hand, a standard SEIR model significantly overestimates the effectiveness of measures. Without taking into account the behavioural component, the epidemic is predicted to be resolved much sooner than when taking it into account and the effectiveness of measures are significantly overestimated.

Introduction

The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19 has led to more than 9,277,214 confirmed cases and more than 3,032,124 deaths as of 21/04/2021 [1]. Apart from the health-related implications, COVID-19 has been affecting almost every aspect of people’s lives and these effects have been unequally distributed [2].

Governments have resorted to health policies known as Non-Pharmaceutical Interventions (NPIs), aimed to reduce the average number of contacts between individuals (physical distancing). While during the first period of the pandemic where no vaccines had been available, NPIs had been the only available measure in reducing the spread of the virus, since a number of vaccines became available in a number of countries, NPIs are being used in parallel to vaccination [35].

A number of studies have explored the effects of NPIs on the contagion dynamics of COVID-19. [611]. One of the focuses of relevant models is the estimation of the effects of NPIs on the rate of spread of the epidemic, captured by the reproduction number, which differs across countries [12] and this can be due to a number of social and economic conditions [13, 14]. Hence, the effectiveness of the different policies depends on how the various measures reduce this parameter. In order to be able to capture the level of this effect, it is necessary to estimate the value of the reproduction number, which in standard compartmental models is assumed to be initially close to constant and changes as a response to active NPIs [12].

However, data which capture mobility levels of individuals show that in a number of countries, including the UK, people took physical distancing measures before governments imposed NPIs. This behaviour, fits well with the insights of models, which take into account behavioural changes over and above NPIs [6, 15] such that the effective reproduction number becomes (at least partly) endogenous. Nonetheless, these works are theoretical and have not been applied to data sets related to COVID-19 so far.

The purpose of our study was threefold: (i) assess the influence of NPIs on physical distancing in the UK, taking explicitly into account the physical distancing behaviour due to observed cases; (ii) extend the standard SEIR model in order to incorporate individuals’ physical distancing behaviour using the analysis from (i); and (iii) use this extended model to study the effectiveness of the NPIs, including the level and timing of NPIs imposed and the possible effects of lifting the relevant measures.

Methods

Data and statistical analysis

In order to assess the influence of both NPIs and the observed information, we analysed the correlation between individuals’ mobility levels and the number of daily confirmed cases of the previous day as reported in the WHO dashboard [1] for three different periods: (a) up to the point when physical distancing advice was given (b) between this advice and enforceable lockdown, and (c) after lockdown. Enforceable lockdown includes NPIs ranging from the closure of public spaces, transportation hubs and shops to forbidding interactions with people outside one’s household and ban any unnecessary travel. Following Buckee et al. (2020) [16], we created an aggregated data time series for physical distancing in the UK using data from Google’s “COVID-19 Community Mobility Reports” [17]. Data in Google’s Community Mobility Reports has undergone differential anonymisation and does not contain any personally identifiable information. Data are generated by aggregation people that have turned on their "location history" setting. Data points are expressed as percentage differences from baseline and validated to be in the expected range of –100 to 100.

Data shows the changes in mobility in six different categories:

  1. Retail and recreation, reporting the mobility trends for places such as restaurants, shopping centres, libraries and cinemas.

  2. Supermarket and pharmacy, capturing the trends for places such as supermarkets, food warehouses and pharmacies

  3. Parks, which shows the mobility trends for places like parks, public beaches, plazas and public gardens.

  4. Public transport, which shows the mobility trends for places that are public transport hubs, such as underground, bus and train stations.

  5. Workplaces, capturing mobility trends to places of work

  6. Residential, which shows mobility trends for places of residence.

We noted that not all of the above categories are relevant for measuring levels of physical distancing, which on one hand are related to both NPIs and to individuals’ behaviour, while on the other are relevant for the contagion dynamics. For this reason, we used the categories “Workplaces”, “Public transport”, “Retail and recreation”. We defined as mobility mt at time t, a weighted average of these three categories. In order to calculate the different weights, we first matched these categories with the relevant ones from the national travel survey, 2018 [18] which includes the following travel categories: Business, Education, Escort education, Shopping, Personal Business, Visiting friends at private home, Visiting friends elsewhere, Entertainment / public activity, Sport, Holiday, Day trip, Other.

We matched the National Travel Survey categories “Holiday”, “Day trip”, “Entertainment / public activity”, “Shopping”, “Visiting friends elsewhere (than home)” to the “Retail and Recreation” mobility trend; “Commuting”, “Business” and “Personal Business” to the “Workplaces” mobility trend. Additionally, we hypothesised that the “Public Transport / Transit” mobility trend uniformly influences both the above trends. We then computed the relative weights of the above activities with regards to the total activities and mapped these weights to the three mobility categories. This gave us relative weights of 0.38 for “Retail and Recreation”, 0.29 for “Workplaces” and 0.33 for “Public Transport/Transit”. We observe that mobility over time resembles a logistic distribution and the same is true for new confirmed cases (ct), (Fig 1).

Fig 1. Mobility and new confirmed cases for the UK 15-02-2020: 14-06-2020.

Fig 1

The gold line represents the 7-day rolling mean of the new confirmed cases per day. Values are scaled to the range of 0–100. The green line represents the weighted average of the percentage drop of mobility trends from baseline. Vertical dashed lines show the timing of various Non-Pharmaceutical Interventions. Mobility data has been downloaded from google mobility trends and is publicly available, [17] new daily cases has been downloaded from the WHO dashboard [1] and is publicly available.

We observed two periods: one with a sharp decrease in mobility and one with a slight increase. The plots of the confirmed cases follow a very similar pattern but in opposite directions. The different NPIs seem to have an effect of the slope of both lines. The fall in confirmed cases happens around 14 days after the NPIs have been introduced and a big fall in mobility has taken place.

Based on this observation, it is reasonable to assume that there is a linear relationship between the two data series and that the available information in one period affects the decision for the next, which means that mt is a linear function of ct-1 ie.

mt=λ0ct1+λ1,

where λ0 captures the effect of daily confirmed cases and λ1 other influences including the effects of NPIs.

However, given that also NPIs affect mobility, we tested this hypothesis for three different periods: before advice, between advice and lockdown, and after lockdown. This hypothesis is supported by very high and significant correlation between the two variables in all three different periods (S1 Fig).

This observation highlights the fact that NPIs are not the only factors which influence mobility which in turn is related to physical distancing levels and the reproduction number of COVID-19. Behaviour should therefore be taken into account in relevant models and policy simulations.

Behavioural SEIR Model

The key variable informing NPIs is the reproduction number, which is the fraction of the transmission rate of the epidemic (βt) over the recovery rate of infected individuals (γ). The daily transmission rate (and hence the basic or effective reproduction number) directly depends on the number contacts per individual, which means that due to the assumption that mobility is a proxy of daily number of contacts we can express βt as

βt=Pmt=ζct1+ε (1)

where P is the probability of getting infected if susceptible, mt is the mobility as defined above ε = Pλ0 and ζ = Pλ1 capture the relative importance of the behavioural component related to observed infections and the NPIs respectively, such that for ζ = 0 only NPIs would affect the level of βt. Note that ζ and ε are the slope and intercept of the linear model fitting the data as described in the previous section.

We divided the population of individuals according to the infection status into susceptible (St), exposed (Et), infected (It) and removed ones (Rt) such that

St+Et+It+Rt=N. (2)

Susceptible subjects might get infected when they contact an infectious individual and if infected, they enter the exposed compartment before the infected one. Following Prem et al. (2020) [8], the infected individuals are split into two further groups where the first group is symptomatic and clinical (ItC) and the second asymptomatic and subclinical (ItSC). The first group is a fraction ρ of the total infected and the second is 1 - ρ of the total.

Accordingly, the evolution of the infection is given by the following set of equations

St+1=StβtStIt/N, (3)
Et+1=(1α)Et+βtStIt/N, (4)
It+1C=ραEt+(1γ)ItC, (5)
It+1SC=(1ρ)αEt+(1γ)ItSC (6)
Rt+1=Rt+γIt, (7)

with It=ItC+ItSC, where βt captures the daily transmission rate of COVID-19 (as above), α is the parameter related to the incubation with 1/α being the average incubation period (in days) and γ is the daily probability that an infected individual becomes removed (as above). Note that the confirmed daily cases ct refer to only the symptomatic, which means that ct = ραEt-1. hence Eq (1) can be expressed as

βt=ζραEt2+ε (8)

We note that intuitively ζ should be negative such that an increase in confirmed cases leads to an increase in physical distancing practices, hence to a reduction in βt.

Eqs (2)–(8) constitute the baseline Behavioural SEIR (BeSEIR) model based on UK data. The last equation captures the behavioural part of the compartmental model based in the UK and may differ for other countries or other epidemics as the linear relationship which we observed may not hold in other jurisdictions or countries.

Results and discussion

Results

We simulated the contagion dynamics in the UK and the different effects of policies over two periods of 200 and 300 days, respectively, with the demographic changes being ignored, hence keeping the total number of individuals as constant. For Eqs (3)–(7), we used values from relevant published works. We used the data from a counterfactual SEIR model with β = β0, γ = 0.133, ρ = 0.4 (Prem et al. 2020) [8], Ν = 50000000 (roughly the number of adults in the UK [19], and started with 1000 people exposed at t = 0. We started our simulations with a seed of 1000 people exposed on Day 0. Genetic analysis has showed 1356 transmission lineages of COVID-19 in the UK [20].

We calibrated the constants of Eq (8) as follows:

For Et-2 = 0, we get β0 = ε. Eq (1) can be expressed as R0γ = Pm0, which means that for m0 = 1 (equivalent to 100% mobility levels) and given values of γ and R0 we can find P and βA, the value of the reproduction number at the time when the NPIs are introduced.

From Flaxman et al. (2020) [12], we set R0 = 3.8, which gives β0 = ε = R0γ = 0.5. We observed that the UK government started implementing measures when new cases per day were 409 [1]. Using the counterfactual BeSEIR model, we chose the time step with the closest value, which was 441 on day 24. Hence, for ραEt-2 = 441, βA = 441ζ + β0

which gives ζ = (βAβ0)/409 = -0.00016.

We then considered the peak in new clinical cases per day as the time of the maximum physical distancing and mt = 0.2 and thus the lowest value of the effective reproduction number. Based on this we calculated the value of βt on that day (at t = 104), which we call βB and is 0.10. Using this value, we calculated the parameters of Eq (8) after the measures. Call these parameters ζ = -0.0001734341 and ε’ = 0.1769653. Using these values, our extended BeSEIR model was able to reproduce the dynamics of contagion in the UK (Fig 2A and 2B).

Fig 2. Behavioural SEIR model simulation for the UK adult population, with measures implemented on Day 24, when the number of new observable cases per day is similar to what was in the UK on 16-03-2020.

Fig 2

Panel A shows the percentage of Exposed and Infected (both clinical and sub-clinical) individuals per day. Panel B shows the reproduction number of the disease (Rt) over time. Panel C shows the cumulative infected people as predicted with the standard SEIR model–blue line vs the BeSEIR model–red line. Panel D shows the infected people at any time point as predicted by the standard SEIR. Panel E shows the infected people at any time point as predicted by the behavioural SEIR. R0 = 3.8, α = 0.15625, γ = 0.1331221, starting seed = 1000 individuals exposed on Day 0.

We compared the simulation results of our model with a standard SEIR model and found that the latter model predicts a number of infections both cumulative (Fig 2C) and per day, much higher than the BeSEIR (Fig 2D and 2E). The difference regarding infections is several orders of magnitude, which highlights the importance of taking into account behavioural factors.

We compared the effectiveness of NPIs between our model and the standard SEIR. As expected in the standard SEIR, the cumulative number of infected individuals is lower than in the BeSEIR (Fig 3A). As in the previous case, the cumulative number differs by several orders of magnitude. We noticed that the reproduction number on the standard SEIR is only affected by NPIs (Fig 3B).

Fig 3. BeSEIR vs standard SEIR with NPIs implemented on Day 24.

Fig 3

Panel A shows the cumulative infected people as predicted with the standard SEIR model–blue line vs the behavioural SEIR model–red line. Panel B shows the reproduction number over time. Panel C shows the infected people at any time point as predicted by the standard SEIR. Panel D shows the infected people at any time point as predicted by the behavioural SEIR.

We tested the impact on the total number of infected individuals and the maximum confirmed daily cases of the delay of (i) implementing the measures (ii) and lifting restrictions. This allowed us to compute the cost in terms of lockdown days in order to reach the same reproduction number. The next graph shows the dynamics of key variables compared to a hypothetical situation when the same measures had been taken 7 days earlier than the actual date of intervention.

We noticed that, while the timing of measures has an important impact on the number of infected individuals (both daily and cumulatively, Fig 4A–4C), the reproduction number is reduced relatively less compared to the scenario where the measures are taken later (Fig 4D). This highlights that all other factors being equal, it may be optimal to have a relatively higher reproduction number with a lower number of infected rather than the opposite. This is due to the fact that the number of infected individuals at any point in time depends both in the reproduction number and the number of infected in the previous period. Hence a later intervention would require a higher reduction in the reproduction number to have the same reduction in infections to an earlier one.

Fig 4. BeSEIR model comparing the effect of measures taken on Day 24, baseline model–red line or measures taken on Day 17, early model–blue line.

Fig 4

A: Percentage of infected individuals. B: Percentage of Removed individuals. C: Percentage of Exposed individuals. D: Reproduction number Re = βt/γ.

Interestingly, we noticed that the maximum number of infected individuals at any point in time using the BeSEIR model is significantly and much more realistically lower than the standard SEIR (Fig 4C and 4D), where it also takes longer for the number of infected to be reduced.

We tested the impact of lifting the measures earlier rather than later and also compared this to the hypothetical case of earlier timing of NPIs. As expected, the most efficient policy would be to both delay lifting physical distancing measures and implementing NPIs early (Fig 5). We noticed that taking the timing regarding on when the measures are lifted plays a less important role (assuming that there will be a lift) compared to the timing of imposing the measures.

Fig 5. BeSEIR model comparing the effect of measures taken on Day 24 and lifted on Day 114, baseline model–red line, measures taken on Day 17 and lifted on Day 114, early model–green line, or measures taken on Day 17 and lifted on Day 107, early model and early lifting–blue line.

Fig 5

A: Percentage of infected individuals. B: Percentage of Removed individuals. C: Percentage of Exposed individuals. D: Reproduction number Re = βt/γ.

Discussion

In this paper argued that in order to be able to evaluate the effectiveness of NPIs, it is necessary to explicitly take account of the behavioural change with regards to physical distancing due to both the relevant NPIs and independent individual choices. If the behaviour of individuals is not taken into account, the levels of physical distancing without measures can be underestimated and similarly the effectiveness of measures can be overestimated. Hence, incorporating an autonomous element of physical distancing can also increase the accuracy of modelling predictions.

Using aggregate mobility data for the UK, we observed that individual mobility levels had been reducing before the measures were taken and have been increasing even before the announcement of relaxation of the measures. We tested whether information regarding confirmed cases can explain the changes in mobility within the different periods of NPIs. In order to also take into consideration, the effects of policies, we considered three distinct periods: before advice, between advice and lockdown, and after lockdown. We found high correlation in all three periods, which confirms the fact that people have been making physical distancing choices using the available information regarding the number of cases which are also assumed to be correlated to the number of deaths. We note that the number of cases reported, at the early phases of the epidemic at least, was a gross underestimate of the real cases. However, the number of deaths has been used in order to infer the number of cases by imposing a somewhat arbitrary death rate. Given this as long as the number of deaths is a fraction of the number of cases the outcome of our BeSEIR model will not change and in addition we acknowledge that people make decisions based on imperfect information.

Our results not only confirm that individual behaviour should be taken into account but also provides a functional form that can be used in models which have similar assumptions regarding physical distancing behaviour [6, 7, 15]. Other studies modelling the COVID-19 pandemic taking into account government interventions implicitly assume a behavioral change as a function of NPIs [2123], whereas our study links the behavioral component to the available information and the current state of the progression of the pandemic. Furthermore, this type of empirical exercise can be replicated across countries to analyse the relative role of social and economic conditions in physical distancing practices along the lines discussed in [13, 14].

This observation raised two policy related questions with regards to the timing of making the interventions and the time of lifting these. Given that individuals react autonomously, policies are less effective compared to a situation where individuals do not act independently. However, it is not clear how much this behaviour would impact the overall results.

We showed that when the level of daily infections is relatively low, more strict measures are required in order to achieve high levels of physical distancing. This means that the same level of measures may be less effective in reducing the reproduction number if these are imposed earlier rather than later. But importantly, this does not mean that early measures are less effective in reducing the overall number of infections. NPIs which are imposed even a week earlier can have an important impact in the reduction of infections.

This finding may give an explanation about the initial spread of the epidemic in countries that were hit first. Given the high uncertainty and the much lower volumes of information the endogenous behavioural component we describe couldn’t have a significant effect in these countries. On the other hand, quickly introduced NPIs in the form of enforceable lockdowns were the only way to reduce the spread of the epidemic.

Conclusion

In order to be able to assess the effects of the different policies, we first extended the standard SEIR model to a BeSEIR one and calibrated it using epidemiological data from previous relevant studies. Our results highlight two issues. First, not taking into account the fact that individuals also react themselves over and above NPIs may lead to very misleading projections with regards to the effectiveness of measures. Second, the fact that even though the reproduction number is a relevant variable for policy purposes, it is not necessarily a measure of success of NPIs. A higher reproduction number with less active cases can be preferable to the opposite can be less challenging to the capacity of a given health system. Of course, the basic reproduction number of the disease as defined by the biological features of the SARS-COV-2 virus is still important as it is predictive of the epidemic curve in the absence of NPIs or changes in human behaviour.

R0Re=βt/γRe=βt/γ

Supporting information

S1 Fig. Scatterplots showing the relationship between the mobility percentage drop from baseline and the logit transformation of new COVID-19 cases per day in the UK.

A regression line is drawn in black with the corresponding 95% confidence interval in grey. We also show the Pearson’s correlation coefficient—"R" and the corresponding p.value—"p" assessing the significance of the correlation coefficient estimate. A: The relationship before the advice for maintaining physical distancing. B: The relationship after the advice for physical distancing but before enforceable lockdown. C: The relationship after lockdown.

(TIF)

Data Availability

All data is publicly available from https://covid19.who.int/?gclid=CjwKCAjwltH3BRB6EiwAhj0IUD_ZYpmWYI5f1P9OYsYlJKTajlyFvk5aXAwQNMNIoL82XsVMfF4LExoC8e4QAvD_BwE https://www.gov.uk/government/collections/national-travel-survey-statistics and https://www.google.com/covid19/mobility?hl=en.

Funding Statement

D.L.B has acted as a consultant on behalf of Oxford Innovation in the last 2 years for Amgen, CODA therapeutic, Bristows, Lilly, Mundipharma and Theranexus. D.L.B has an MRC Industrial Partnership grant with Astra Zeneca. D.L.B is a senior Wellcome clinical scientist (202747/Z/16/Z). G.B and D.L.B are funded by Diabetes UK (19/0005984). Sponsor’s had no role in study design, in the collection, analysis and interpretation of data; in the writing of the article; and in the decision to submit it for pub-lication.

References

  • 1.WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. [cited 2020 Jun 25]. Available from: https://covid19.who.int/?gclid=CjwKCAjwltH3BRB6EiwAhj0IUD_ZYpmWYI5f1P9OYsYlJKTajlyFvk5aXAwQNMNIoL82XsVMfF4LExoC8e4QAvD_BwE
  • 2.Ahmed F, Ahmed N, Pissarides C, Stiglitz J. Why inequality could spread COVID-19. Lancet Public Health. 2020;5(5):e240. doi: 10.1016/S2468-2667(20)30085-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. The Lancet Infectious Diseases. 2021. Jun 1;21(6):793–802. doi: 10.1016/S1473-3099(21)00143-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Betti M, Bragazzi NL, Heffernan JM, Kong J, Raad A. Integrated vaccination and non-pharmaceutical interventions based strategies in Ontario, Canada, as a case study: a mathematical modelling study. Journal of The Royal Society Interface. 18(180):20210009. doi: 10.1098/rsif.2021.0009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gozzi N, Bajardi P, Perra N. The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout. PLOS Computational Biology. 2021. Sep 10;17(9):e1009346. doi: 10.1371/journal.pcbi.1009346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Di Guilmi C, Galanis G, Baskozos G. A Behavioural SIR Model and its Implications for Physical Distancing. Review of Behavioral Economics [Internet]. August 20212;Forthcoming(2021–10–15). Available from: http://hdl.handle.net/10453/150156 [Google Scholar]
  • 7.Flaschel P, Galanis G, Tavani D, Venezian R. Pandemics and aggregate demand: A framework for policy analysis [Internet]. Centre for Applied Macroeconomic Analysis. The Australian National University; [cited 2021 Sep 23]. Available from: https://cama.crawford.anu.edu.au/publication/cama-working-paper-series/18348/pandemics-and-aggregate-demand-framework-policy-analysis [Google Scholar]
  • 8.Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study. Lancet Public Health. 2020. May;5(5):e261–70. doi: 10.1016/S2468-2667(20)30073-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020. May 22;368(6493):860–8. doi: 10.1126/science.abb5793 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet. 2020. Mar 21;395(10228):931–4. doi: 10.1016/S0140-6736(20)30567-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand [Internet]. 20. 2020. Mar [cited 2020 Apr 14]. Available from: http://spiral.imperial.ac.uk/handle/10044/1/77482 [Google Scholar]
  • 12.Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020. Aug;584(7820):257–61. doi: 10.1038/s41586-020-2405-7 [DOI] [PubMed] [Google Scholar]
  • 13.Galanis G, Hanieh A. Incorporating Social Determinants of Health into Modelling of COVID-19 and other Infectious Diseases: A Baseline Socio-economic Compartmental Model. Soc Sci Med. 2021. Apr;274:113794. doi: 10.1016/j.socscimed.2021.113794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gouzoulis G, Galanis G. The impact of financialisation on public health in times of COVID-19 and beyond. Sociology of Health & Illness. 2021;43(6):1328–34. doi: 10.1111/1467-9566.13305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Eksin C, Paarporn K, Weitz JS. Systematic biases in disease forecasting—The role of behavior change. Epidemics. 2019. Jun;27:96–105. doi: 10.1016/j.epidem.2019.02.004 [DOI] [PubMed] [Google Scholar]
  • 16.Buckee CO, Balsari S, Chan J, Crosas M, Dominici F, Gasser U, et al. Aggregated mobility data could help fight COVID-19. Science. 2020. Apr 10;368(6487):145–6. doi: 10.1126/science.abb8021 [DOI] [PubMed] [Google Scholar]
  • 17.COVID-19 Community Mobility Report [Internet]. COVID-19 Community Mobility Report. [cited 2020 Jun 25]. Available from: https://www.google.com/covid19/mobility?hl=en
  • 18.National Travel Survey [Internet]. GOV.UK. [cited 2020 Jun 25]. Available from: https://www.gov.uk/government/collections/national-travel-survey-statistics
  • 19.Projected UK adult population for 2018—Office for National Statistics [Internet]. [cited 2021 Sep 23]. Available from: https://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/projectedukadultpopulationfor2018
  • 20.du Plessis L, McCrone JT, Zarebski AE, Hill V, Ruis C, Gutierrez B, et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021. Feb 12;371(6530):708–12. doi: 10.1126/science.abf2946 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rodríguez J, Patón M, Uratani JM, Acuña JM. Modelling the impact of interventions on the progress of the COVID-19 outbreak including age segregation. PLOS ONE. 2021. Mar 15;16(3):e0248243. doi: 10.1371/journal.pone.0248243 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sharma M, Mindermann S, Rogers-Smith C, Leech G, Snodin B, Ahuja J, et al. Understanding the effectiveness of government interventions in Europe’s second wave of COVID-19 [Internet]. 2021. Mar [cited 2021 Sep 22] p. 2021.03.25.21254330. Available from: https://www.medrxiv.org/content/10.1101/2021.03.25.21254330v1 [Google Scholar]
  • 23.Haug N, Geyrhofer L, Londei A, Dervic E, Desvars-Larrive A, Loreto V, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav. 2020. Dec;4(12):1303–12. doi: 10.1038/s41562-020-01009-0 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Prasenjit Mitra

16 Sep 2021

PONE-D-21-13349The effectiveness of Non-Pharmaceutical Interventions in reducing the COVID-19 contagion in the UK, an observational and modelling study.PLOS ONE

Dear Dr. Baskozos,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR: Please modify the manuscript==============================

Please submit your revised manuscript by Oct 30 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Prasenjit Mitra, MD, CBiol, MRSB, MIScT, FLS, FACSc, FAACC

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Please upload a copy of Supporting Information Figure 1 which you refer to in your text on page 4.

4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors would need to revise the manuscript in line with the following;

Introduction:

The statement on the second paragraph may need to be revised to reflect the present day realities of availability of vaccines but with problems of vaccine hesitance.

Methods:

The authors may need to state how the data from Google’s “COVID-19 Community Mobility Reports were validated and abstracted.

Discussion:

The discussion section will need to revised from just discussing the findings of this study solely to brining into context findings of others studies

Conclusion:

The authors may consider summarising the conclusion as it is too lengthy in this present form

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tolulope Olumide Afolaranmi

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Nov 29;16(11):e0260364. doi: 10.1371/journal.pone.0260364.r002

Author response to Decision Letter 0


27 Sep 2021

Dear editors,

Thank you for giving us the opportunity to submit a revised manuscript to PLOS One. Below is a detailed response to all the points raised by the reviewer. Our point by point response is in bold. In addition to the points discussed below we have edited the manuscript to be fully concordant with the formatting templates provided, amended the funding statement to reflect all funding sources, uploaded the missing “Supporting Information Figure 1” and reviewed our reference list. We thank the editor for providing constructive feedback on this issues. We have taken all their comments into account and we feel that they made the manuscript stronger.

Yours sincerely,

Georgios Baskozos

Reviewer #1: The authors would need to revise the manuscript in line with the following;

Introduction:

The statement on the second paragraph may need to be revised to reflect the present day realities of availability of vaccines but with problems of vaccine hesitance.

Thank you very much for this comment. The reviewer is right. We have changed this statement accordingly both in the introduction and the discussion.

Methods:

The authors may need to state how the data from Google’s “COVID-19 Community Mobility Reports were validated and abstracted.

We have added a short paragraph when we present Google’s “COVID-19 Community Mobility Reports” where we discuss the expected range of values, anonymisation and data aggregation. We believe this additional information shows how data were validate to be within the expected range and provided full details on data collection and aggregation.

Discussion:

The discussion section will need to revised from just discussing the findings of this study solely to brining into context findings of others studies

We have added a short paragraph which relates our work and results with other closely related studies and added the appropriate references. We have also moved part of our conclusion to the discussion section.

Conclusion:

The authors may consider summarising the conclusion as it is too lengthy in this present form

We have significantly shortened the conclusion.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Prasenjit Mitra

9 Nov 2021

The effectiveness of Non-Pharmaceutical Interventions in reducing the COVID-19 contagion in the UK, an observational and modelling study.

PONE-D-21-13349R1

Dear Dr. Baskozos,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Prasenjit Mitra, MD, CBiol, MRSB, MIScT, FLS, FACSc, FAACC

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all the the review comments and the manuscript is now publication worthy.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Tolulope Olumide Afolaranmi

Acceptance letter

Prasenjit Mitra

11 Nov 2021

PONE-D-21-13349R1

The effectiveness of Non-Pharmaceutical Interventions in reducing the COVID-19 contagion in the UK, an observational and modelling study.

Dear Dr. Baskozos:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Prasenjit Mitra

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Scatterplots showing the relationship between the mobility percentage drop from baseline and the logit transformation of new COVID-19 cases per day in the UK.

    A regression line is drawn in black with the corresponding 95% confidence interval in grey. We also show the Pearson’s correlation coefficient—"R" and the corresponding p.value—"p" assessing the significance of the correlation coefficient estimate. A: The relationship before the advice for maintaining physical distancing. B: The relationship after the advice for physical distancing but before enforceable lockdown. C: The relationship after lockdown.

    (TIF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All data is publicly available from https://covid19.who.int/?gclid=CjwKCAjwltH3BRB6EiwAhj0IUD_ZYpmWYI5f1P9OYsYlJKTajlyFvk5aXAwQNMNIoL82XsVMfF4LExoC8e4QAvD_BwE https://www.gov.uk/government/collections/national-travel-survey-statistics and https://www.google.com/covid19/mobility?hl=en.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES